Paper · 20537908
Adoptive transfer of unselected or leukemia-reactive T-cells in the treatment of relapse following allogeneic hematopoietic cell transplantation.
O'Reilly RJ and 4 others. Semin Immunol, 2010. Cited by 28 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Adoptive transfer of unselected or leukemia-reactive T-cells in the treatment of relapse following allogeneic hematopoietic cell transplantation. Papers, record 20537908. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/20537908
On this page
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Adoptive Transfer | Major topic |
| Hematopoietic Stem Cell Transplantation | Major topic |
| Immunotherapy | Major topic |
| Leukemia | Major topic |
| T-Lymphocytes | Major topic |
| Transplantation, Homologous | Major topic |
| Amino Acid Sequence | |
| Animals | |
| Clinical Trials as Topic | |
| Epitopes, T-Lymphocyte | |
| Humans | |
| Mice | |
| Molecular Sequence Data | |
| Secondary Prevention | |
| WT1 Proteins |
Source PubMed
Grants4
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| P01 CA023766 | NCI NIH HHS | United States | P01CA023766 | PubMed and NIH | NIH RePORTER |
| P01 CA106450 | NCI NIH HHS | United States | P01CA106450 | PubMed and NIH | NIH RePORTER |
| CA23766 | NCI NIH HHS | United States | P01CA023766 | PubMed and NIH | NIH RePORTER |
| CA106450 | NCI NIH HHS | United States | P01CA106450 | PubMed and NIH | NIH RePORTER |
Trials1
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record |
|---|---|---|---|
| NCT05350163 | T-cell Receptor α/β Depleted Donor Lymphocyte Infusion | Background |
Source ClinicalTrials.gov
Comments and corrections0
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
None in this release.
References176
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 12,115,544 | Overexpression of the Wilms' tumor gene WT1 in de novo lung cancers. | Int J Cancer | 2002 | https://conductscience.org/library/papers/12115544 | PubMed |
| 2 | 6,186,923 | A minor transplantation antigen detected by MHC-restricted cytotoxic T lymphocytes during graft-versus-host disease. | Nature | 1983 | https://conductscience.org/library/papers/6186923 | PubMed |
| 3 | 9,490,709 | Cytotoxic T-lymphocyte-defined human minor histocompatibility antigens with a restricted tissue distribution. | Blood | 1998 | https://conductscience.org/library/papers/9490709 | PubMed |
| 4 | 12,473,218 | T-cell therapy targeting minor histocompatibility Ags for the treatment of leukemia and renal-cell carcinoma. | Cytotherapy | 2002 | https://conductscience.org/library/papers/12473218 | PubMed |
| 5 | 3,310,002 | Graft versus leukemia effect in man: the relapse rate of acute leukemia is lower after allogeneic than after syngeneic marrow transplantation. | Prog Clin Biol Res | 1987 | https://conductscience.org/library/papers/3310002 | PubMed |
| 6 | 14,585,640 | Adoptive cellular therapy for early cytomegalovirus infection after allogeneic stem-cell transplantation with virus-specific T-cell lines. | Lancet | 2003 | https://conductscience.org/library/papers/14585640 | PubMed |
| 7 | 16,575,000 | High WT1 expression after induction therapy predicts high risk of relapse and death in pediatric acute myeloid leukemia. | J Clin Oncol | 2006 | https://conductscience.org/library/papers/16575000 | PubMed |
| 8 | 12,070,282 | Interleukin 15 is required for proliferative renewal of virus-specific memory CD8 T cells. | J Exp Med | 2002 | https://conductscience.org/library/papers/12070282 | PubMed |
| 9 | 12,969,970 | Female donors contribute to a selective graft-versus-leukemia effect in male recipients of HLA-matched, related hematopoietic stem cell transplants. | Blood | 2004 | https://conductscience.org/library/papers/12969970 | PubMed |
| 10 | 3,896,348 | Effects of in vitro depletion of T cells in HLA-identical allogeneic marrow grafts. | Blood | 1985 | https://conductscience.org/library/papers/3896348 | PubMed |
1 to 10 of 176
See all 176 referencesCited by16
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 28 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 34,433,633 | Phase I dose escalation safety and feasibility study of autologous WT1-sensitized T cells for the treatment of patients with recurrent ovarian cancer. | J Immunother Cancer | 2021 | https://conductscience.org/library/papers/34433633 | PubMed |
| 32,184,297 | Identification of the Targets of T-cell Receptor Therapeutic Agents and Cells by Use of a High-Throughput Genetic Platform. | Cancer Immunol Res | 2020 | https://conductscience.org/library/papers/32184297 | PubMed |
| 27,897,332 | Recent advances in T-cell immunotherapy for haematological malignancies. | Br J Haematol | 2017 | https://conductscience.org/library/papers/27897332 | PubMed |
| 27,479,183 | HLA-DPB1 mismatch alleles represent powerful leukemia rejection antigens in CD4 T-cell immunotherapy after allogeneic stem-cell transplantation. | Leukemia | 2017 | https://conductscience.org/library/papers/27479183 | PubMed |
| 26,926,229 | Low incidence of GvHD with T-cell depleted allografts facilitates further treatments for post-transplantation relapse in AML and MDS. | Bone Marrow Transplant | 2016 | https://conductscience.org/library/papers/26926229 | PubMed |
| 26,834,952 | Novel immunotherapeutic approaches for the treatment of acute leukemia (myeloid and lymphoblastic). | Ther Adv Hematol | 2016 | https://conductscience.org/library/papers/26834952 | PubMed |
| 26,648,070 | Adoptive Immunotherapy For Leukemia With Ex vivo Expanded T Cells. | Curr Drug Targets | 2017 | https://conductscience.org/library/papers/26648070 | PubMed |
| 26,056,592 | Adoptive T-cell therapy for Leukemia. | Mol Cell Ther | 2014 | https://conductscience.org/library/papers/26056592 | PubMed |
| 26,034,113 | T-cell and natural killer cell therapies for hematologic malignancies after hematopoietic stem cell transplantation: enhancing the graft-versus-leukemia effect. | Haematologica | 2015 | https://conductscience.org/library/papers/26034113 | PubMed |
| 25,987,253 | Affinity maturation of T-cell receptor-like antibodies for Wilms tumor 1 peptide greatly enhances therapeutic potential. | Leukemia | 2015 | https://conductscience.org/library/papers/25987253 | PubMed |
1 to 10 of 16
See all 16 cited byGenes40
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CD33 | 945 | PubTator's text mining | https://conductscience.org/library/genes/945 | NCBI Gene |
| CD34 | 947 | PubTator's text mining | https://conductscience.org/library/genes/947 | NCBI Gene |
| CD4 | 920 | PubTator's text mining | https://conductscience.org/library/genes/920 | NCBI Gene |
| CD80 | 941 | PubTator's text mining | https://conductscience.org/library/genes/941 | NCBI Gene |
| CD86 | 942 | PubTator's text mining | https://conductscience.org/library/genes/942 | NCBI Gene |
| CD8A | 925 | PubTator's text mining | https://conductscience.org/library/genes/925 | NCBI Gene |
| CSF1 | 1,435 | PubTator's text mining | https://conductscience.org/library/genes/1435 | NCBI Gene |
| CSF2 | 1,437 | PubTator's text mining | https://conductscience.org/library/genes/1437 | NCBI Gene |
| CTLA4 | 1,493 | PubTator's text mining | https://conductscience.org/library/genes/1493 | NCBI Gene |
| CXADRP1 | 653,108 | PubTator's text mining | https://conductscience.org/library/genes/653108 | NCBI Gene |
1 to 10 of 40
See all 40 genesDrugs0
The drugs whose trials, in the Pipelines release, list the paper.
None in this release.
Data0
The data bank entries PubMed's record names. Trial numbers are under Trials.
None in this release.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/20537908
GET https://conductscience.org/api/papers/v1/20537908/references?page=2